Ashley Hernandez-Gutierrez, Sonoor Majid, Adam Eberle, Ashley Choi, Parand Sorkhdini, Dongqin Yang, Alina Xiaoyu Yang, Carmelissa Norbrun, Chuan Hua He, Chang-min Lee, Chun Geun Lee, Jack A. Elias, Yang Zhou, Phospholipid Scramblase-1 Regulates Innate Type 2 Inflammation in Mouse Lung via CRTH2-dependent Mechanisms. Journal of Clinical Investigation, Aug 1, 2023.

Cao Y, Rudrakshala J, Williams R, Rodriguez S, Sorkhdini P, Yang AX, Mundy M, Yang D, Palmisciano A, Walsh T, Delcompare C, Caine T, Tomasi L, Shea BS, Zhou Y. CRTH2 Mediates Profibrotic Macrophage Differentiation and Promotes Lung Fibrosis. Am J Respir Cell Mol Biol. 2022 May 18. doi: 10.1165/rcmb.2021-0504OC. Epub ahead of print. PMID: 35585756.

Xiuna Sun, Erika Nakajima, Dongqin Yang, Corey E. Ventetuolo, Julie Braza, Alexander Vang, Jason Aliotta, Debasree Banerjee, Mandy Pereira, Grayson Baird, Qing Lu, Elizabeth O. Harrington, Sharon Rounds, Chun Geun Lee, Gaurav Choudhary, James R. Klinger, Yang Zhou, Chitinase 3-like-1 contributes to the development of pulmonary vascular remodeling in pulmonary hypertension, JCI Insight, 2022 Sep 22

Andrea Gonsalves, Parand Sorkhdini, Jasmine Bazinet, Moez Ghumman, Dinesh Dhamecha, Yang Zhou, Jyothi U. Menon, Development and characterization of lung surfactant – coated nanoparticles to improve lung retention for sustained pulmonary drug delivery, Biomaterials Advances, 2023 Jul;150:213430

Suchitra Kamle, Bing Ma, Chang Min Lee, Gail Schor, Yang Zhou, Chun Geun Lee, Jack A Elias, Host chitinase 3-like-1 is a universal therapeutic target for SARS-CoV-2 viral variants in COVID-19, Elife, 2022 Jun 23;11:e78273

Lee SY, Lee CM, Ma B, Kamle S, Elias JA, Zhou Y, Lee CG. Targeting Chitinase 1 and Chitinase 3-Like 1 as Novel Therapeutic Strategy of Pulmonary Fibrosis. Front Pharmacol. 2022 Mar 17;13:826471. doi: 10.3389/fphar.2022.826471. PMID: 35370755; PMCID: PMC8969576.

Jakaria MG, Sorkhdini P, Yang D, Zhou Y, Meenach SA. Lung cell membrane-coated nanoparticles capable of enhanced internalization and translocation in pulmonary epithelial cells. Int J Pharm. 2022 Feb 5;613:121418. doi: 10.1016/j.ijpharm.2021.121418. Epub 2021 Dec 22. PMID: 34954003; PMCID: PMC8792290.

Kamle S, Ma B, He CH, Akosman B, Zhou Y, Lee CM, El-Deiry WS, Huntington K, Liang O, Machan JT, Kang MJ, Shin HJ, Mizoguchi E, Lee CG, Elias JA.  Chitinase 3-like-1 is a therapeutic target that mediates the effects of aging in COVID-19. JCI Insight. 2021 Nov 8;6(21):e148749. doi: 10.1172/jci.insight.148749. PMID: 34747367; PMCID: PMC8663553.

Ghumman M, Dhamecha D, Gonsalves A, Fortier L, Sorkhdini P, Zhou Y, Menon JU. Emerging drug delivery strategies for idiopathic pulmonary fibrosis treatment. Eur J Pharm Biopharm. 2021 Jul;164:1-12. doi: 10.1016/j.ejpb.2021.03.017. Epub 2021 Apr 18. PubMed PMID: 33882301; PubMed Central PMCID: PMC8154728.

Velázquez-Díaz P, Nakajima E, Sorkhdini P, Hernandez-Gutierrez A, Eberle A, Yang D, Zhou Y. Hermansky-Pudlak Syndrome and Lung Disease: Pathogenesis and Therapeutics. Front Pharmacol. 2021;12:644671. doi: 10.3389/fphar.2021.644671. eCollection 2021. Review. PubMed PMID: 33841163; PubMed Central PMCID: PMC8028140.

Rajagopal K, Bryant AJ, Sahay S, Wareing N, Zhou Y, Pandit LM, Karmouty-Quintana H. Idiopathic pulmonary fibrosis and pulmonary hypertension: Heracles meets the Hydra. Br J Pharmacol. 2021 Jan;178(1):172-186. doi: 10.1111/bph.15036. Epub 2020 Apr 7. Review. PubMed PMID: 32128790; PubMed Central PMCID: PMC7910027.

Zhou Y, He CH, Yang DS, Nguyen T, Cao Y, Kamle S, Lee CM, Gochuico BR, Gahl WA, Shea BS, Lee CG, Elias JA. Galectin-3 Interacts with the CHI3L1 Axis and Contributes to Hermansky-Pudlak Syndrome Lung Disease. J Immunol. 2018 Mar 15;200(6):2140-2153. doi: 10.4049/jimmunol.1701442. Epub 2018 Feb 2. PubMed PMID: 29427412; PubMed Central PMCID: PMC5839999.

Zhou Y, He CH, Herzog EL, Peng X, Lee CM, Nguyen TH, Gulati M, Gochuico BR, Gahl WA, Slade ML, Lee CG, Elias JA. Chitinase 3-like-1 and its receptors in Hermansky-Pudlak syndrome-associated lung disease. J Clin Invest. 2015 Aug 3;125(8):3178-92. doi: 10.1172/JCI79792. Epub 2015 Jun 29. PubMed PMID: 26121745; PubMed Central PMCID: PMC4563747.

Zhou Y, Peng H, Sun H, Peng X, Tang C, Gan Y, Chen X, Mathur A, Hu B, Slade MD, Montgomery RR, Shaw AC, Homer RJ, White ES, Lee CM, Moore MW, Gulati M, Lee CG, Elias JA, Herzog EL. Chitinase 3-like 1 suppresses injury and promotes fibroproliferative responses in Mammalian lung fibrosis. Sci Transl Med. 2014 Jun 11;6(240):240ra76. doi: 10.1126/scitranslmed.3007096. PubMed PMID: 24920662; PubMed Central PMCID: PMC4340473.

He CH, Lee CG, Dela Cruz CS, Lee CM, Zhou Y, Ahangari F, Ma B, Herzog EL, Rosenberg SA, Li Y, Nour AM, Parikh CR, Schmidt I, Modis Y, Cantley L, Elias JA. Chitinase 3-like 1 regulates cellular and tissue responses via IL-13 receptor α2. Cell Rep. 2013 Aug 29;4(4):830-41. doi: 10.1016/j.celrep.2013.07.032. Epub 2013 Aug 22. PubMed PMID: 23972995; PubMed Central PMCID: PMC3988532.

Zhou Y, Kang MJ, Jha BK, Silverman RH, Lee CG, Elias JA. Role of ribonuclease L in viral pathogen-associated molecular pattern/influenza virus and cigarette smoke-induced inflammation and remodeling. J Immunol. 2013 Sep 1;191(5):2637-46. doi: 10.4049/jimmunol.1300082. Epub 2013 Aug 2. PubMed PMID: 23913960; PubMed Central PMCID: PMC3750064.

Zhou Y, Lee JY, Lee CM, Cho WK, Kang MJ, Koff JL, Yoon PO, Chae J, Park HO, Elias JA, Lee CG. Amphiregulin, an epidermal growth factor receptor ligand, plays an essential role in the pathogenesis of transforming growth factor-β-induced pulmonary fibrosis. J Biol Chem. 2012 Dec 7;287(50):41991-2000. doi: 10.1074/jbc.M112.356824. Epub 2012 Oct 19. PubMed PMID: 23086930; PubMed Central PMCID: PMC3516745.

Complete List of Published Work in MyBibliography:  

http://www.ncbi.nlm.nih.gov/sites/myncbi/1luOfpcwskV5g/bibliography/40350446/public/?sort=date&direction=ascending